United Therapeutics Corporation - Special Call

Core Points - United Therapeutics Corporation held a conference call to discuss the Phase 3 TETON-2 trial results [1][2] - The call included forward-looking statements regarding the company's expectations and beliefs about future events, which are subject to risks and uncertainties [2] Company Developments - The conference call featured remarks on the progress and results of clinical trials related to United Therapeutics' products [2] - The company emphasized that the information shared is intended to educate investors and is not meant for medical decision-making [2]